Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
dechra.com

See what CB Insights has to offer

Partners & Customers

6

About Dechra

Dechra (DPH:LN) is an international specialist veterinary pharmaceuticals products business. The company's expertise is in the development, manufacture, and sales and marketing of products exclusively for veterinarians worldwide.

Dechra Headquarter Location

24 Cheshire Avenue Lostock Gralam, Northwich

Cheshire, England, CW9 7UA,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Dechra Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Dechra Rank

Latest Dechra News

Piedmont Animal Health is being sold to UK firm in $210M deal

Jul 27, 2022

Greensboro-based Piedmont Animal Health, an innovator of more than 30 pet medicines sold by major global brands, will be sold to Dechra Pharmaceuticals of England for $210 million in cash. The post Piedmont Animal Health is being sold to UK firm in $210M deal first appeared on WRAL TechWire.

Dechra Acquisitions

8 Acquisitions

Dechra acquired 8 companies. Their latest acquisition was Piedmont Animal Health on July 20, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/20/2022

Other

$99M

Acquired

1

1/6/2020

Subscribe to see more

$99M

Subscribe to see more

10

8/29/2019

Subscribe to see more

$99M

Subscribe to see more

10

10/19/2018

Subscribe to see more

$99M

Subscribe to see more

10

9/16/2016

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/20/2022

1/6/2020

8/29/2019

10/19/2018

9/16/2016

Investment Stage

Other

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Dechra Partners & Customers

6 Partners and customers

Dechra has 6 strategic partners and customers. Dechra recently partnered with DSM on December 12, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

12/3/2021

Partner

Netherlands

DSM Biomedical and Dechra partner.

Mike Eldred , President of Dechra Limited North America stated : `` We are extremely excited to have partnered with DSM Biomedical for their innovative and patented regenerative medicine devices .

1

2/9/2021

Licensor

United States

Subscribe to see more

Subscribe to see more

10

10/16/2019

Licensor

Canada

Subscribe to see more

Subscribe to see more

10

3/6/2017

Licensor

Canada

Subscribe to see more

Subscribe to see more

10

1/13/2011

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

12/3/2021

2/9/2021

10/16/2019

3/6/2017

1/13/2011

Type

Partner

Licensor

Licensor

Licensor

Partner

Business Partner

Country

Netherlands

United States

Canada

Canada

United States

News Snippet

DSM Biomedical and Dechra partner.

Mike Eldred , President of Dechra Limited North America stated : `` We are extremely excited to have partnered with DSM Biomedical for their innovative and patented regenerative medicine devices .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Dechra Team

1 Team Member

Dechra has 1 team member, including current Chief Executive Officer, Ian D Page.

Name

Work History

Title

Status

Ian D Page

Chief Executive Officer

Current

Name

Ian D Page

Work History

Title

Chief Executive Officer

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.